Delcath Systems

About:

Delcath Systems is an interventional oncology company that focuses on the treatment of metastatic liver cancer.

Website: http://www.delcath.com

Twitter/X: delcathsystems

Top Investors: Avenue Capital Group, Biotechnology Value Fund, Silicon Valley Bank, Logos Capital, Vivo Capital

Description:

Delcath Systems is an interventional oncology company that focuses on the treatment of metastatic liver cancer. Its proprietary product Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure.